BTIG Research Cuts Docusign (NASDAQ:DOCU) Price Target to $60.00

Docusign (NASDAQ:DOCU) had its price target cut by analysts at BTIG Research from $70.00 to $60.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. BTIG Research’s price target indicates a potential upside of 17.79% from the company’s previous close.

A number of other brokerages have also weighed in on DOCU. JPMorgan Chase & Co. lowered their price objective on Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Citigroup restated a “neutral” rating on shares of Docusign in a research note on Friday. UBS Group lowered their price objective on Docusign from $75.00 to $54.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Bank of America started coverage on Docusign in a research note on Tuesday, March 31st. They set an “underperform” rating and a $52.00 price objective for the company. Finally, Piper Sandler decreased their target price on Docusign from $75.00 to $52.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $60.40.

Docusign Stock Down 2.8%

Shares of NASDAQ DOCU opened at $50.94 on Friday. Docusign has a fifty-two week low of $40.16 and a fifty-two week high of $94.67. The business has a 50 day moving average price of $47.74 and a two-hundred day moving average price of $54.21. The firm has a market cap of $9.90 billion, a PE ratio of 34.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.92.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings data on Thursday, June 4th. The company reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The firm had revenue of $830.24 million during the quarter, compared to analyst estimates of $824.71 million. During the same quarter last year, the firm earned $0.90 EPS. Docusign’s quarterly revenue was up 8.7% on a year-over-year basis. On average, analysts anticipate that Docusign will post 1.76 earnings per share for the current year.

Docusign declared that its Board of Directors has approved a stock repurchase program on Tuesday, March 17th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to buy up to 21% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Insider Buying and Selling

In related news, Director Mary Agnes Wilderotter sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $48.15, for a total value of $144,450.00. Following the sale, the director owned 59,803 shares of the company’s stock, valued at approximately $2,879,514.45. This trade represents a 4.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $46.84, for a total value of $281,040.00. Following the completion of the sale, the executive directly owned 79,233 shares in the company, valued at approximately $3,711,273.72. This trade represents a 7.04% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 65,126 shares of company stock worth $3,107,875. 0.59% of the stock is currently owned by insiders.

Institutional Trading of Docusign

Several hedge funds have recently made changes to their positions in DOCU. Central Pacific Bank Trust Division bought a new stake in shares of Docusign in the 4th quarter worth approximately $25,000. Modus Advisors LLC bought a new stake in shares of Docusign in the 4th quarter worth approximately $27,000. Torren Management LLC bought a new stake in shares of Docusign in the 4th quarter worth approximately $28,000. Aventura Private Wealth LLC bought a new stake in shares of Docusign in the 4th quarter worth approximately $30,000. Finally, True Wealth Design LLC lifted its holdings in shares of Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: DocuSign beat Q1 estimates, posting adjusted EPS of $1.09 versus $1.00 expected and revenue of about $830.2 million versus $824.7 million forecast, with sales up 8.7%-9% year over year. DocuSign (DOCU) Q1 Earnings and Revenues Beat Estimates
• Positive Sentiment: The company raised its revenue outlook for fiscal 2027 and said demand is improving for its AI-powered Intelligent Agreement Management platform, which supports the growth story. DocuSign Nudges Revenue Outlook Higher After First-Quarter Profit Rises
• Positive Sentiment: Investors are also encouraged by new AI-related product integrations, including ChatGPT and Codex, which could broaden adoption of DocuSign’s platform. DocuSign (DOCU) Valuation Check After Q1 Beat And New AI Agreement Management Launch
• Neutral Sentiment: DocuSign also highlighted record stock buybacks and continued product launches, but these items appear secondary to the company’s main earnings and guidance narrative. Docusign Inc (DOCU) Q1 2027 Earnings Call Highlights
• Negative Sentiment: Despite the beat, the stock fell in premarket/after-hours trading because guidance did not offer much upside beyond Wall Street expectations, leaving some investors disappointed. DocuSign Tops First-Quarter Forecasts, but Soft Outlook Weighs on Shares (DOCU)

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.